Academic qualifications:

  • 1995-2000: B. Med. Department of Clinical Medicine, Taishan Medical College, Shandong, China
  • 2000-2003: M. Med. Shanghai Medical College, Fudan University, Shanghai China
  • 2005-2008: Ph.D. Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong

Previous academic positions held:
  • 2003-2009: Lecturer & Resident, Shanghai Medical College, Fudan University, Shanghai China
  • 2009-2012 Physician-in-Charge, Department of Endocrinology and Metabolism, Shanghai Tenth People¡¯s Hospital, Tongji Universtiy, Shanghai China.
Present academic position:
  • 2012- Associate Professor, Advanced Institute of Translational Medicine, Tongji University, Shanghai China
  • 2012- Postdoctoral Research Fellow (Honorary), Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University

Previous relevant research work:
  • Technical expertise: Bone bioimaging, Bone biology, Bone biomechanics, Bone histomorphometry
  • Research area: RNAi-based or phytotherapy-based translational research in osteoporosis, osteonecrosis

Publications (Representative publications in recent years):
  1. Zhang Ge#, SHENG H#, et al. Continuous occurrence of both insufficient neovascularization and elevated vascular permeability during inadequate repair of steroid-associated osteonecrotic lesions. Arthritis and Rheumatism, Oct,60(10)£º2966£­77£¬2009. (#:Co-first author).
  2. SHENG H, Zhang G, Wang YX, et al. Functional Perfusion MRI Predicts Steroid-Associated Osteonecrosis: An Experiment Study in Rabbits. Journal of Orthopaedic Research, 2009 Jun;27(6):742-7.
  3. Zhang G#, Wang XL#, SHENG H#, et al. Constitutional flavonoids derived from Epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis not via direct action by themselves on potential cellular targets. PLoS One. 2009 Jul 29;4(7):e6419 (##:Co-first autho)
  4. SHENG H, Qin L, Zhang G, Cheung WH, et al. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development. Journal of Orthopaedic Surgery and Research, 4: 2£­15, 2007.
  5. SHENG H, QU Jingjing, XU Bei, et al. Estrogen prevents pioglitazone-induced apoptosis in osteoblasts. Diabetes.60(S1) :A258, 2011.
  6. SHENG H, Ge Zhang, Wenjun Li, et al. Rosiglitazone induces osteoblasts apoptosis via PPAR¦Ã-GSK3¦Â pathway. Bone. 47(S3):S438-S439, 2010.
  7. SHENG H£¬Li WJ, Sheng CJ, et al. The progress of osteoporosis diagnosis and treatment. Chinese Journal of Geriatrics. 2012.